10-Q: Hims & Hers Health Reports Strong Q2 2024 Results, Revenue Surges 52%

Hims & Hers Health, Inc. announced a 52% year-over-year increase in revenue for the second quarter of 2024, driven by growth in online sales and subscribers.

Summary

• Hims & Hers Health, Inc. reported a significant 52% increase in total revenue for the second quarter of 2024, reaching $315.6 million, compared to $207.9 million in the same period last year.
• Online revenue grew by 53% to $306.8 million, while wholesale revenue increased by 31% to $8.8 million.
• The company's subscriber base grew by 43% year-over-year, reaching 1.9 million subscribers.
• Monthly online revenue per average subscriber increased to $57, up from $53 in the prior year.
• Average order value (AOV) also saw a substantial increase, rising 27% to $121.
• Net income for the quarter was $13.3 million, a significant improvement compared to a net loss of $7.2 million in the second quarter of 2023.
• The company's gross profit margin was 81% for the quarter.
• Operating expenses increased by 37% to $245.6 million, driven by investments in marketing, operations, and technology.
• Adjusted EBITDA for the quarter was $39.3 million, compared to $10.6 million in the same period last year.
• The company repurchased 1,609,043 shares of Class A common stock for $19.9 million during the quarter.
• Hims & Hers also announced a new share repurchase program of up to $100 million.

Sentiment

Score: 8

Explanation: The document presents a very positive outlook with strong revenue growth, increased subscribers, and a return to profitability. The company's strategic investments and share repurchase program further enhance the positive sentiment. However, the increase in operating expenses and the competitive landscape temper the sentiment slightly.

Positives

• The company achieved a significant increase in revenue, driven by both online and wholesale channels.
• The subscriber base grew substantially, indicating strong customer acquisition and retention.
• Monthly revenue per subscriber and average order value both increased, reflecting higher customer spending.
• The company achieved net income for the quarter, a significant improvement from the prior year's net loss.
• Adjusted EBITDA showed substantial growth, indicating improved operational efficiency.
• The company has a strong cash position with $129.3 million in cash and cash equivalents and $98.0 million in short-term investments.
• The company is actively repurchasing shares, indicating confidence in its future prospects.

Negatives

• Operating expenses increased significantly, driven by investments in marketing, operations, and technology.
• Cost of revenue increased by 56%, outpacing revenue growth, which slightly decreased gross margin.
• The company continues to invest heavily in marketing, which may impact short-term profitability.

Risks

• The company's future performance depends on its ability to attract new customers and retain existing ones.
• The company faces competition from other telehealth providers, traditional healthcare providers, and retailers.
• The company's business is subject to various healthcare and other regulations, and failure to comply could result in penalties.
• Security breaches and data loss could compromise sensitive information and harm the company's reputation.
• The company's reliance on third-party service providers exposes it to risks related to their performance and security.
• The company's international expansion plans are subject to various risks, including regulatory and political uncertainties.
• The company's dual-class stock structure concentrates voting power with the CEO, which could limit investors' influence.
• The market price of the company's Class A common stock may be volatile.

Future Outlook

The company expects to continue to focus on long-term growth, investing in fulfillment capabilities, marketing, product offerings, and customer experience. They also plan to expand into new health and wellness specialties and are working to enhance their offerings and expand the breadth of health and wellness products and services offered on their websites and mobile applications.

Management Comments

• Management monitors Online Revenue and Wholesale Revenue to track total revenue generation.
• Management believes that they have the technical platform, distributed provider network, and access to clinical capabilities to lead the migration of routine office visits to a digital format.
• Management believes that their existing cash resources are sufficient to support planned operations for the next 12 months.

Industry Context

The company operates in the rapidly evolving telehealth and digital health market, which is experiencing increased adoption and competition. The company's growth is driven by the increasing demand for convenient and affordable healthcare solutions, as well as the expansion of telehealth services and the use of technology in healthcare.

Comparison to Industry Standards

• Hims & Hers' revenue growth of 52% year-over-year in Q2 2024 is significantly higher than the average growth rate of many traditional healthcare providers and retailers, indicating a strong market position in the digital health space.
• The company's subscriber growth of 43% year-over-year demonstrates a strong ability to attract and retain customers, which is a key metric for subscription-based businesses in the telehealth industry.
• The increase in monthly online revenue per average subscriber and average order value suggests that Hims & Hers is successfully monetizing its customer base and expanding its product offerings.
• Compared to other telehealth companies, Hims & Hers' focus on a wide range of specialties, including sexual health, dermatology, mental health, and weight loss, provides a competitive advantage.
• The company's investment in its own Affiliated Pharmacies and fulfillment capabilities is a strategic move to control the supply chain and improve customer experience, which is not common among all telehealth providers.
• The company's Adjusted EBITDA of $39.3 million in Q2 2024, compared to $10.6 million in Q2 2023, indicates a significant improvement in operational efficiency and profitability, which is a positive sign compared to many other companies in the digital health space that are still struggling to achieve profitability.
• The company's share repurchase program demonstrates confidence in its future prospects and is a positive signal to investors, which is not a common practice among all companies in the digital health industry.

Management Changes

Legal Proceedings

• The company is a party to litigation, various claims, and other legal and administrative proceedings arising in the ordinary course of business.
• Management is not currently aware of any matters that are reasonably likely to have a material adverse impact on the company's business, financial position, results of operations, or cash flows.

Related Party Transactions

• The company recorded $0.3 million and less than $0.1 million, respectively, within operating expenses on the unaudited condensed consolidated statements of operations and comprehensive income (loss) for payments made to Vouched, a related-party company that provides identity verification services for the three months ended June 30, 2024 and 2023, respectively.
• The company recorded $1.5 million and $1.0 million, respectively, for payments made to Vouched for the six months ended June 30, 2024 and 2023, respectively.
• For the three and six months ended June 30, 2023, the Company recorded $1.2 million and $2.2 million, respectively, within operating expenses on the unaudited condensed consolidated statements of operations and comprehensive income (loss) for payments made to Terminal, Inc., a former related-party company that provides professional services to the Company, primarily to support engineering and operations functions.

Stakeholder Impact

• Shareholders will benefit from the company's strong financial performance and share repurchase program.
• Employees may benefit from the company's growth and potential for career advancement.
• Customers will benefit from the company's expanded product offerings and improved customer experience.
• Suppliers and partners will benefit from the company's continued growth and expansion.

Next Steps

• The company intends to continue to invest in its fulfillment and operating capabilities, including its Affiliated Pharmacies and warehousing facilities.
• The company expects to continue to make significant investments in marketing to acquire new customers.
• The company expects to continue to make investments in product offerings and customer experience.
• The company will continue to evaluate the likelihood of achieving the performance metrics on a quarterly basis for performance RSUs.
• The company intends to use the new share repurchase program to repurchase shares on a discretionary basis from time to time, subject to general business and market conditions and other investment opportunities.

Key Dates

Keywords

telehealth, online pharmacy, digital health, subscription model, direct-to-consumer, healthcare, e-commerce, compounding, GLP-1, weight loss